Cellular senescence and aging: The role of B-MYB

Aging Cell

Volumn 13, Issue 5, 2014, Pages 773-779

  Mowla, Sophia N ^a   Lam, Eric W F ^b   Jat, Parmjit S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Aging; B MYB; Cellular senescence; Growth arrest; MuvB

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MYB RELATED PROTEIN B; PROTEIN MYB; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; PROTEIN C MYB;

CELL AGING; CELL CYCLE CHECKPOINT; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL DEATH; CELL GROWTH; CELL MATURATION; ENERGY METABOLISM; G2 PHASE CELL CYCLE CHECKPOINT; GROWTH DISORDER; HUMAN; LIFESPAN; NEOPLASM; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; AGING; ANIMAL; CELL PROLIFERATION; GENETICS; PHYSIOLOGY;

PYRONIA TITHONUS;

AGING; ANIMALS; CELL AGING; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; HUMANS; PROTO-ONCOGENE PROTEINS C-MYB; SIGNAL TRANSDUCTION;

EID: 84908570573     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12242     Document Type: Review

References (69)

1. Ahlbory D, Appl H, Lang D, Klempnauer KH (2005) Disruption of B-myb in DT40 cells reveals novel function for B-Myb in the response to DNA-damage. Oncogene 24, 7127-7134.
2. Anders L, Ke N, Hydbring P, Choi YJ, Widlund HR, Chick JM, Zhai H, Vidal M, Gygi SP, Braun P, Sicinski P (2011) A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20, 620-634.
3. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM (2011) Clearance of p16Ink4a-positive senescent cells delays aging-associated disorders. Nature 479, 232-236.
4. Ben Porath I, Weinberg RA (2004) When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113, 8-13.
5. Ben-Porath I, Weinberg RA (2005) The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 37, 961-976.
6. Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522.
7. Campisi J (2013) Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685-705.
8. Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer and aging. Cell 130, 223-233.
9. DeCaprio JA (2013) Human papillomavirus type 16 E7 perturbs DREAM to promote cellular proliferation and mitotic gene expression. Oncogene, doi:10.1038/onc.2013.449.
10. Di Micco R, Cicalese A, Fumagalli M, Dobreva M, Verrecchia A, Pelicci PG, di Fagagna Fd (2008) DNA damage response activation in mouse embryonic fibroblasts undergoing replicative senescence and following spontaneous immortalization. Cell Cycle 7, 3601-3606.
11. Down CF, Millour J, Lam EW, Watson RJ (2012) Binding of FOXM1 to G2/M gene promoters is dependent upon B-Myb. Biochim. Biophys. Acta 1819, 855-862.
12. Flynn JM, O'Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, Zykovich A, Mooney SD, Strong R, Rosen CJ, Kapahi P, Nelson MD, Kennedy BK, Melov S (2013) Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 12, 851-862.
13. García P, Frampton J (2006) The transcription factor B-Myb is essential for S-phase progression and genomic stability in diploid and polyploid megakaryocytes. J. Cell Sci. 119(Pt. 8), 1483-1493.
14. Gilbert LA, Hemann MT (2010) DNA damage-mediated induction of a chemoresistant niche. Cell 143, 355-366.
15. Golde TE, Miller VM (2009) Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases. Alzheimers Res. Ther. 1, 5.
16. Grassilli E, Salomoni P, Perrotti D, Franceschi C, Calabretta B (1999) Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. Cancer Res. 59, 2451-2456.
17. Hardy K, Mansfield L, Mackay A, Benvenuti S, Ismail S, Arora P, O'Hare MJ, Jat PS (2005) Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol. Biol. Cell 16, 943-953.
18. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395.
19. Huang YB, Wu J, Li R, Wang P, Han L, Zhang Z, Tong T (2011) B-Myb delays cell aging by repressing p16INK4A transcription. Cell. Mol. Life Sci. 68, 893-901.
20. Jeck WR, Siebold AP, Sharpless NE (2012) A meta-analysis of GWAS and age-associated diseases. Aging Cell 11, 727-731.
21. Jia K, Chen D, Riddle DL (2004) The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131, 3897-3906.
22. Johung K, Goodwin EC, DiMaio D (2007) Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J. Virol. 81, 2102-2116.
23. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S (2004) Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14, 885-890.
24. Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M (2013) Cancer genetics and genomics of human FOX family genes. Cancer Lett. 328, 198-206.
25. Khan S, Chuturgoon AA, Naidoo DP (2012) Telomeres and atherosclerosis. Cardiovasc. J. Afr. 23, 563-571.
26. Khongkow P, Karunarathna U, Khongkow M, Gong C, Gomes AR, Yagüe E, Monteiro LJ, Kongsema M, Zona S, Man EP, Tsang JW, Coombes RC, Wu KJ, Khoo US, Medema RH, Freire R, Lam EW (2013) FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene, doi:10.1038/onc.2013.457.
27. Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA (2012) A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. BJU Int. 110(Pt. C), E1237-E1248.
28. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS (2008) Oncogene induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031.
29. Lam EW, Watson RJ (1993) An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12, 2705-2713.
30. Lam EW, Robinson C, Watson RJ (1992) Characterization and cell cycle-regulated expression of mouse B-myb. Oncogene 7, 1885-1890.
31. Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, Sato M, Wang K, Sumazin P, Kustagi M, Bisikirska BC, Basso K, Beltrao P, Krogan N, Gautier J, Dalla-Favera R, Califano A (2010) A human B-cell interactome identifies Myb and FOXM1 as master regulators of proliferation in germinal centers. Mol. Syst. Biol. 6, 377.
32. Li J, Bai X, Cui S, Fu B, Chen X (2012) Effect of rapamycin on high glucose-induced autophagy impairment, oxidative stress and premature senescence in rat mesangial cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao 32, 467-471.
33. Lin D, Fiscella M, O'Connor PM, Jackman J, Chen M, Luo LL (1994) Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest. Proc. Natl Acad. Sci. USA 91, 10079-10083.
34. Ling Q, Meng C, Chen Q, Xing D (2014) Activated ERK/FOXM1 Pathway by Low-Power Laser Irradiation Inhibits UVB-Induced Senescence Through Down-Regulating p21 Expression. J. Cell. Physiol. 229, 108-116.
35. Livi CB, Hardman RL, Christy BA, Dodds SG, Jones D, Williams C, Strong R, Bokov A, Javors MA, Ikeno Y, Hubbard G, Hasty P, Sharp ZD (2013) Rapamycin extends life span of Rb1 + /- mice by inhibiting neuroendocrine tumors. Aging 5, 100-110.
36. Longo VD, Finch CE (2003) Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299, 1342-1346.
37. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153, 1194-1217.
38. Lowe SW, Sherr CJ (2003) Tumor suppression by Ink4a±Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77-83.
39. Ly DH, Lockhart DJ, Lerner RA, Schultz PG (2000) Mitotic misregulation and human aging. Science 287, 2486-2492.
40. Martinez I, DiMaio D (2011) B-Myb, cancer, senescence, and microRNAs. Cancer Res. 71, 5370-5373.
41. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D (2011) miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc. Natl Acad. Sci. USA 108, 522-527.
42. Masoro E, Austad S (1996) The evolution of the antiaging action of dietary restriction: a hypothesis. J. Gerontol. A Biol. Sci. Med. Sci. 51, B387-B391.
43. Masselink H, Vastenhouw N, Bernards R (2001) B-myb rescues ras-induced premature senescence, which requires its transactivation domain. Cancer Lett. 171, 87-101.
44. Mita MM, Mita A, Rowinsky EK (2003) The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol. Ther. 2(Suppl. 1), S169-S177.
45. Monickaraj F, Aravind S, Nandhini P, Prabu P, Sathishkumar C, Mohan V, Balasubramanyam M (2013) Accelerated fat cell aging links oxidative stress and insulin resistance in adipocytes. J. Biosci. 38, 113-122.
46. Morgensztern D, McLeod HL (2005) PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs 16, 797-803.
47. Muñoz-Espín D, Cañamero M, Maraver A, Gómez-López G, Contreras J, Murillo-Cuesta S, Rodríguez-Baeza A, Varela-Nieto I, Ruberte J, Collado M, Serrano M (2013) Programmed cell senescence during mammalian embryonic development. Cell 155, 1104-1118.
48. Ness SA (2003) Myb protein specificity: evidence for a context-specific transcription factors code. Blood Cells Mol. Dis. 31, 192-200.
49. Quaas M, Müller GA, Engeland K (2012) p53 can repress transcription of cell cycle genes through a p21 (WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements. Cell Cycle 11, 4661-4672.
50. Roussel M, Saule S, Lagrou C, Rommens C, Beug H, Graf T, Stehelin D (1979) Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature 281, 452-455.
51. Rovillain E, Mansfield L, Caetano C, Alvarez-Fernandez M, Caballero OL, Medema RH, Hummerich H, Jat PS (2011) Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30, 2356-2366.
52. Rufini A, Tucci P, Celardo I, Melino G (2013) Senescence and aging: the critical roles of p53. Oncogene 32, 5219-5243.
53. Rushton JJ, Davis LM, Lei W, Mo X, Leutz A, Ness SA (2003) Distinct changes in gene expression induced by A-Myb. B-Myb and C-Myb proteins. Oncogene 22, 308-313.
54. Ryan KM, Phillips AC, Vousden KH (2001) Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337.
55. Sadasivam S, DeCaprio JA (2013) The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat. Rev. Cancer 13, 585-595.
56. Sadasivam S, Duan S, DeCaprio JA (2012) The MuvB complex sequentially recruits B-Myb and FOXM1 to promote mitotic gene expression. Genes Dev. 26, 474-489.
57. Sala A (2005) B-Myb, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur. J. Cancer 41, 2479-2484.
58. Sala A, Calabretta B (1992) Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc. Natl Acad. Sci. USA 89, 10415-10419.
59. Sala A, Casella I, Bellon T, Calabretta B, Watson RJ, Peschle C (1996) B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. J. Biol. Chem. 271, 9363-9367.
60. Schwab R, Caccamo A, Bettuzzi S, Anderson J, Sala A (2007) B-Myb is hypophosphorylated and resistant to degradation in neuroblastoma: implications for cell survival. Blood Cells Mol. Dis. 39, 263-271.
61. Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V, Yosef R, Pilpel N, Krizhanovsky V, Sharpe J, Keyes WM (2013) Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119-1130.
62. Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L, Nelson PS (2012) Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat. Med. 18, 1359-1368.
63. Tarasov KV, Tarasova YS, Tam WL, Riordon DR, Elliott ST, Kania G, Li J, Yamanaka S, Crider DG, Testa G, Li RA, Lim B, Stewart CL, Liu MYB, Van Eyk JE, Wersto RP, Wobus AM, Boheler KR (2008) B-Myb is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS ONE 3, e2478.
64. Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 123, 966-972.
65. Vaughan S, Jat PS (2011) Deciphering the role of nuclear factor-κB in cellular senescence. Aging 3, 913-919.
66. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH (2005) Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 25, 10875-10894.
67. Yamauchi T, Ishidao T, Nomura T, Shinagawa T, Tanaka Y, Yonemura S, Ishii S (2008) A B-Myb complex containing clathrin and filamin is required for mitotic spindle function. EMBO J. 27, 1852-1862.
68. Ye H, Li L, Guo H, Yin Y (2012) B-Myb is a substrate of GSK3-like kinase BIN2 and acts as a corepressor of BES1 in brassinosteroid signaling pathway in Arabidopsis. Proc. Natl Acad. Sci. USA 109, 20142-20147.
69. Zhan M, Riordon DR, Yan B, Tarasova YS, Bruweleit S, Tarasov KV, Li RA, Wersto RP, Boheler KR (2012) The B-Myb transcriptional network guides cell cycle progression and fate decisions to sustain self-renewal and the identity of pluripotent stem cells. PLoS ONE 7, e42350.